POMDOCTOR Ltd
POMDOCTOR Ltd is a China-based digital healthcare company built around an internet hospital platform, physician network, and pharmaceutical supply chain operations. Its business combines online patient services, pharmaceutical fulfillment, and data-enabled healthcare services through operating subsidiaries and related healthcare partnerships.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2023–2025
Liiketoiminta
Osuus liikevaihdostaPatient-facing internet hospital services, consultations, prescriptions, and medication support.
Online pharmaceutical access, sales, purchase, and fulfillment support.
Recurring membership services for chronic disease monitoring and intervention.
Institutional healthcare services for hospitals and enterprise customers.
Real-world study and real-world data services for pharmaceutical and healthcare partners.
Asiakkaat
Pomdoctor serves individual patients who use its internet hospital, online consultation, prescription, and medication services. It also sells into pharmaceutical companies and healthcare organizations that need patient-management support, treatment-analysis data, and commercialization channels. Hospitals and enterprise healthcare customers are another important segment because they use the platform’s physician access, supply chain, and service infrastructure.
They buy online consultations, prescriptions, and medication-related support through the internet hospital platform.
They subscribe to ongoing monitoring, alerts, health reports, and physician-supported management.
They buy sales, purchase, distribution, and RWS/RWD-related services to reach patients and support evidence generation.
They use enterprise services tied to physician access, patient management, and healthcare operations.
Strategia
Pomdoctor is using its internet hospital and pharmaceutical supply chain as the operating base for newer digital-health offerings. Its stated priorities are to expand AI-enabled chronic disease management, remote monitoring, institutional services, and real-world data capabilities while preserving its existing healthcare businesses.
Recurring memberships can increase repeat usage and deepen the patient relationship beyond single transactions.
Pharma and healthcare partners can use de-identified data for evidence generation and treatment analysis.
B2B hospital and institutional services diversify revenue beyond direct patient transactions.
Maantiede
Pomdoctor is headquartered in Guangzhou, China, and its operating platform is centered on the Chinese healthcare market. The company is also listed in the United States, which broadens its investor base, while the business itself remains tied to China-based healthcare delivery, pharmaceutical supply chains, and regulatory oversight.
Riskit
Pomdoctor depends on healthcare regulation, patient authorization, and data standardization to monetize data-driven services, which makes compliance and privacy risk central. The business also faces execution risk in turning its chronic-disease and RWD initiatives into scalable commercial offerings, while its China-focused operating footprint exposes it to regulatory and reimbursement changes in one market.
- Patient authorization and data privacy complianceVaikutus: KorkeaTodennäköisyys: Korkea
RWS and RWD services require de-identification, consent, and regulatory review before data can be used commercially.
Kohdistuu: Healthcare data services and research partnerships
- Execution risk in new AI and membership productsVaikutus: KorkeaTodennäköisyys: Kohtalainen
The company must convert monitoring and AI features into scalable, recurring revenue without disrupting core operations.
Kohdistuu: AI-enabled chronic disease subscriptions
- Regulatory risk in China healthcareVaikutus: KorkeaTodennäköisyys: Kohtalainen
Internet hospital, pharmaceutical, and healthcare-data activities are subject to changing rules and oversight.
Kohdistuu: Domestic healthcare operations
- Pharma partner dependenceVaikutus: KeskitasoTodennäköisyys: Korkea
Commercial relationships with pharmaceutical companies are important for distribution, supply chain, and data services.
Kohdistuu: Pharmaceutical collaborations
Kirjanpito
Harkinnanvaraiset erätConsultations, subscriptions, supply chain sales, and data services may each require different recognition methods.
Vaikutus: Affects reported revenue timing and quarter-to-quarter comparability
Membership and enterprise arrangements may require judgment on service period and variable consideration.
Vaikutus: Can change revenue deferral and recognized margins
The company references consolidated subsidiaries and VIEs in its filings.
Vaikutus: Affects which operations and liabilities are included in the financial statements
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Zhongchao Inc.
ZCMD · Services-Educational Services
111, Inc.
YI · Retail-Drug Stores and Proprietary Stores
Waterdrop Inc.
WDH · Insurance Agents, Brokers & Service
Longduoduo Co Ltd
LDDD · Services-Health Services
Longduoduo Co Ltd is a U.S.-listed company with operating subsidiaries in Inner Mongolia and Beijing that generates revenue from two main activities: direct…
Dogecoin Cash, Inc.
DOGP · Services-Personal Services
Concord Medical Services Holdings Ltd
CCM · Services-Offices & Clinics of Doctors of Medicine
Concord Medical Services Holdings Ltd is a medical services group headquartered in Beijing, with operations centered on hospital, clinic, and other healthcare service assets in China.
Päivitetty: 28.9.2026